Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 2.455 |
|---|---|
| 52-week range | 2.200 – 3.690 |
| Return, 1 month / 3 months | −2.4% / +1.4% |
| Return, 1 year / 3 years | −31.2% / +4.8% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 30.8% |
| Worst drawdown (1 year) | -35.9% |
| Average daily value traded | 3.03M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 2.455 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 722 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.2% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.4% | ||
| From 52-week high | -28.8% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | -13.3% | ||
| 12-month return, skipping the last month | -29.6% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.9% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.03M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −2.4% |
| 3 months | +1.4% |
| 6 months | −13.3% |
| 1 year | −31.2% |
| 3 years | +4.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2.546 / 2.710 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.092 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jul 2025 | HKD 0.0321 |
| 26 Aug 2024 | HKD 0.0217 |
| 4 Jul 2024 | HKD 0.0757 |
| 5 Jun 2023 | HKD 0.0798 |
| 5 Jul 2022 | HKD 0.0859 |
| 1 Jun 2021 | HKD 0.0608 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.